– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -8.01 | -30.7840122982 | 26.02 | 26.7 | 17.8101 | 285787 | 22.20943714 | CS |
4 | -7.015 | -28.031968032 | 25.025 | 29.35 | 17.8101 | 248101 | 24.75725924 | CS |
12 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
26 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
52 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
156 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
260 | -3.49 | -16.2325581395 | 21.5 | 29.35 | 17.8101 | 350576 | 24.21355152 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約